<VariationArchive VariationID="1325386" VariationName="NM_001605.3(AARS1):c.2067dup (p.Tyr690fs)" VariationType="Duplication" Accession="VCV001325386" Version="3" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2021-11-29" MostRecentSubmission="2022-03-05">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1315642" VariationID="1325386">
      <GeneList>
        <Gene Symbol="AARS1" FullName="alanyl-tRNA synthetase 1" GeneID="16" HGNC_ID="HGNC:20" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="70252298" stop="70289506" display_start="70252298" display_stop="70289506" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="70286296" stop="70323411" display_start="70286296" display_stop="70323411" Strand="-" />
          </Location>
          <OMIM>601065</OMIM>
          <Haploinsufficiency last_evaluated="2018-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=AARS">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=AARS">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001605.3(AARS1):c.2067dup (p.Tyr690fs)</Name>
      <CanonicalSPDI>NC_000016.10:70258142:GG:GGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="70258142" stop="70258143" display_start="70258142" display_stop="70258143" variantLength="1" positionVCF="70258142" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="70292045" stop="70292046" display_start="70292045" display_stop="70292046" variantLength="1" positionVCF="70292045" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>Y690fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.70258144dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.70258144dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.70292047dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.70292047dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_023191.1" sequenceAccession="NG_023191" sequenceVersion="1" change="g.36367dup">
            <Expression>NG_023191.1:g.36367dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001605.3" sequenceAccession="NM_001605" sequenceVersion="3" change="c.2067dup" MANESelect="true">
            <Expression>NM_001605.3:c.2067dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001596.2" sequenceAccession="NP_001596" sequenceVersion="2" change="p.Tyr690fs">
            <Expression>NP_001596.2:p.Tyr690fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001605.2" sequenceAccession="NM_001605" sequenceVersion="2" change="c.2067dupC">
            <Expression>NM_001605.2:c.2067dupC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_359" sequenceAccession="LRG_359">
            <Expression>LRG_359:g.36367dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_359t1" sequenceAccession="LRG_359t1">
            <Expression>LRG_359t1:c.2067dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="601065.0006" DB="OMIM" />
        <XRef Type="rs" ID="2152153611" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001605.3(AARS1):c.2067dup (p.Tyr690fs) AND Developmental and epileptic encephalopathy, 29" Accession="RCV001806265" Version="9">
        <ClassifiedConditionList TraitSetID="21420">
          <ClassifiedCondition DB="MedGen" ID="C4225361">Developmental and epileptic encephalopathy, 29</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-03-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-03-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-11-29" MostRecentSubmission="2022-03-05">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">28493438</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="21420" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33278" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 29</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 29</ElementValue>
                <XRef ID="MONDO:0014593" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE29</ElementValue>
                <XRef Type="MIM" ID="616339" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16092" />
                <XRef ID="16092" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="442835" DB="Orphanet" />
              <XRef ID="C4225361" DB="MedGen" />
              <XRef ID="MONDO:0014593" DB="MONDO" />
              <XRef Type="MIM" ID="616339" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4021796" SubmissionDate="2022-03-02" DateLastUpdated="2022-03-05" DateCreated="2022-01-08">
        <ClinVarSubmissionID localKey="601065.0006_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 29" title="AARS1, 1-BP DUP, 2067C_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 29" />
        <ClinVarAccession Accession="SCV002051753" DateUpdated="2022-03-05" DateCreated="2022-01-08" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-02">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 sisters, born of unrelated parents, with developmental and epileptic encephalopathy-29 (DEE29; 616339), Nakayama et al. (2017) identified compound heterozygous mutations in the AARS1 gene: a 1-bp duplication (c.2067dupC, NM_001605.2), resulting in a frameshift and premature termination (Tyr690LeufsTer3), and c.2738G-A transition, resulting in a gly913-to-asp (G913D; 601065.0007) substitution at a highly conserved residue in the C-terminal domain that is important for editing activity. The mutations, which were found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. Analysis of patient-derived cells showed significantly decreased AARS1 protein levels, to 3 to 12% of controls; no truncated protein was detected. In vitro functional expression studies showed that the mutations caused an 85% and 73% reduction, respectively, in catalytic activity compared to controls, as well as a defect in editing activity causing misacylation. Of note, the G913D mutation retained editing activity, whereas the frameshift mutation disrupted editing activity. The findings were consistent with a loss of function. The patients had onset of infantile spasms and seizures in the first months of life associated with hypsarrhythmia on EEG; both patients were later diagnosed clinically with Lennox-Gastaut syndrome. The parents, who were each heterozygous carriers of one of the variants, were clinically unaffected.</Attribute>
              <Citation>
                <ID Source="PubMed">28493438</ID>
              </Citation>
              <XRef DB="OMIM" ID="616339" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AARS1" />
          </GeneList>
          <Name>AARS1, 1-BP DUP, 2067C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DUP, 2067C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601065.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 29</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4021796" TraitType="Disease" MappingType="Name" MappingValue="DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 29" MappingRef="Preferred">
        <MedGen CUI="C4225361" Name="Developmental and epileptic encephalopathy, 29" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002018015</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

